Atazanavir
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Drug reference
elagolix
Oral GnRH Receptor Antagonist · Hormone Antagonist
Oral GnRH Receptor AntagonistHormone Antagonist
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- AtazanavirSevereDatabaseDDInter
- BenzhydrocodoneSevereDatabaseDDInter
- BerotralstatSevereDatabaseDDInter
- BoceprevirSevereDatabaseDDInter
Mechanism
Elagolix is an oral GnRH receptor antagonist that suppresses gonadotropin secretion, leading to a hypoestrogenic state that improves endometriosis symptoms.
Indications
endometriosis (improving dysmenorrhea and pelvic pain)
Side effects
Common
hot flashesincreased serum lipids
Serious
- reduction in bone mineral density
Drug interactions
Benzhydrocodone
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Berotralstat
Severe
Database
Drug interaction classified as: absorption
Source: DDInter
Boceprevir
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Butorphanol
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Ceritinib
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Clarithromycin
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Cobicistat
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Conivaptan
Severe
Database
Drug interaction classified as: metabolism
Source: DDInter
Cyclosporine
Severe
Database
Clinical effect not specified
Source: DDInter
Delavirdine
Severe
Database
Clinical effect not specified
Source: DDInter
Edoxaban
Severe
Database
Clinical effect not specified
Source: DDInter
Ask House about elagolix
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team